EFPIA

Views & Analysis

European pharma: why #WeWontRest in developing breakthrough ...

Andrew Powrie-Smith from EFPIA talks about the European pharmaceutical industry organisation's new #WeWontRest campaign, which highlights the sector's efforts to find better treatments and cure

Views & Analysis

Huge scale of Brexit threat to Europe’s medicines supplies r...

New survey reveals the huge task facing pharma in keeping medicines moving around Europe after Brexit.

News

FDA takes big step towards manufacturing harmonisation with ...

FDA agrees to recognise some EU inspections for the first time

News

European union flag against parliament in Brussels, Belgium

Gene therapy trials held back by fragmented EU rules

Biotech and pharma organisations are calling for EU countries to harmonise regulations, or otherwise face falling behind in cutting-edge gene and cell therapy trials.

News

Brexit could cause drug supply chaos, industry warns

Leaders from associations representing the entire EU and UK pharmaceutical sector have written a joint letter to chief negotiators warning of the potential impact of an 'unorderly' Brexit o

News

Don't let Brexit disrupt European Medicines Agency, warn pha...

Heads of R&D at all major pharma companies have come together to express their concerns about severe disruption to the European Medicines Agency (EMA) as it faces a Brexit-induced reloc

European pharma: why #WeWontRest in developing breakthrough ...

Huge scale of Brexit threat to Europe’s medicines supplies r...

FDA takes big step towards manufacturing harmonisation with ...

Gene therapy trials held back by fragmented EU rules

Brexit could cause drug supply chaos, industry warns

Don't let Brexit disrupt European Medicines Agency, warn pha...

Late-breakers to look out for at ASCO 2026

Discover a new era of healthcare panel engagement: Grounded ...

EFPIA

Editor's Picks